Adherence to European Association of Urology and National Comprehensive Cancer Network Guidelines Criteria for Inguinal and Pelvic Lymph Node Dissection in Penile Cancer Patients-A Survey Assessment in German-speaking Countries on Behalf of the European Prospective Penile Cancer Study Group.
Guideline adherence
Inguinal lymphadenectomy
Pelvic lymphadenectomy
Penile cancer
Squamous cell carcinoma of the penis
Journal
European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
12
12
2019
revised:
27
01
2020
accepted:
05
02
2020
pubmed:
25
2
2020
medline:
14
4
2022
entrez:
25
2
2020
Statut:
ppublish
Résumé
Urologists' adherence to European Association of Urology and National Comprehensive Cancer Network guideline recommendations to perform inguinal (ILND) and pelvic (PLND) lymph node dissection in penile cancer (PC) patients is not known. To assess a German-speaking European cohort of urologists based on their criteria to perform ILND and PLND in PC patients. A 14-item survey addressing general issues of PC treatment was developed and sent to 45 clinical centers in Germany (n = 34), Austria (n = 8), Switzerland (n = 2), and Italy (n = 1). Two of the 14 questions assessed the criteria to perform ILND and ipsilateral PLND. Correct responses for ILND and PLND criteria were assessed. Based on a multivariate logistic-regression-model, criteria independently predicting guideline adherence were identified. In total, 557 urologists participated in the survey, of whom 43.5%, 19.3%, and 37.2% were residents in training, certified, and in leading positions, respectively. ILND and PLND criteria were correctly identified by 35.2% and 23.9%, respectively. Of the participants, 23.3% used external sources for survey completion. The use of auxiliary tools (odds ratio [OR] 1.57; p[ Our results demonstrate overall suboptimal knowledge of the correct indications to perform ILND and PLND in PC patients among the surveyed urologists. We propose that governments and healthcare providers should be encouraged to centralize PC management. The management of inguinal and pelvic lymph nodes is crucial for the survival of penile cancer patients. Disease rarity mandates referral to clinical practice guidelines for appropriate treatment selection.
Sections du résumé
BACKGROUND
BACKGROUND
Urologists' adherence to European Association of Urology and National Comprehensive Cancer Network guideline recommendations to perform inguinal (ILND) and pelvic (PLND) lymph node dissection in penile cancer (PC) patients is not known.
OBJECTIVE
OBJECTIVE
To assess a German-speaking European cohort of urologists based on their criteria to perform ILND and PLND in PC patients.
DESIGN, SETTING, AND PARTICIPANTS
METHODS
A 14-item survey addressing general issues of PC treatment was developed and sent to 45 clinical centers in Germany (n = 34), Austria (n = 8), Switzerland (n = 2), and Italy (n = 1).
INTERVENTION
METHODS
Two of the 14 questions assessed the criteria to perform ILND and ipsilateral PLND.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
METHODS
Correct responses for ILND and PLND criteria were assessed. Based on a multivariate logistic-regression-model, criteria independently predicting guideline adherence were identified.
RESULTS AND LIMITATIONS
CONCLUSIONS
In total, 557 urologists participated in the survey, of whom 43.5%, 19.3%, and 37.2% were residents in training, certified, and in leading positions, respectively. ILND and PLND criteria were correctly identified by 35.2% and 23.9%, respectively. Of the participants, 23.3% used external sources for survey completion. The use of auxiliary tools (odds ratio [OR] 1.57; p[
CONCLUSIONS
CONCLUSIONS
Our results demonstrate overall suboptimal knowledge of the correct indications to perform ILND and PLND in PC patients among the surveyed urologists. We propose that governments and healthcare providers should be encouraged to centralize PC management.
PATIENT SUMMARY
RESULTS
The management of inguinal and pelvic lymph nodes is crucial for the survival of penile cancer patients. Disease rarity mandates referral to clinical practice guidelines for appropriate treatment selection.
Identifiants
pubmed: 32089496
pii: S2405-4569(20)30061-4
doi: 10.1016/j.euf.2020.02.005
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
843-849Informations de copyright
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.